Six months of isoflavone supplement increases fat-free mass in obese-sarcopenic postmenopausal women: a randomized double-blind controlled trial

被引:49
作者
Aubertin-Leheudre, M.
Lord, C.
Khalil, A.
Dionne, I. J.
机构
[1] Res Ctr Aging, Sherbrooke, PQ, Canada
[2] Fac Phys Educ & Sports, Sherbrooke, PQ, Canada
[3] Univ Sherbrooke, Dept Med, Sherbrooke, PQ J1K 2R1, Canada
关键词
menopause; sarcopenia; muscle mass; phytoestrogens; appendicular fat-free mass; muscle mass index;
D O I
10.1038/sj.ejcn.1602695
中图分类号
R15 [营养卫生、食品卫生]; TS201 [基础科学];
学科分类号
100403 [营养与食品卫生学];
摘要
Objective: The aim of this study was to verify if six months of isoflavone supplementation could increase fat-free mass (FFM) and muscle mass index (MMI=appendicular FFM/height(2)) in obese-sarcopenic postmenopausal women. Design: Double-blind randomized study. Subject: Eighteen sarcopenic-obese women completed the study (12 on isoflavones and six on placebo). Body composition was measured by dual-energy X-ray absorptiometry. Subjects ingested 70mg of isoflavones per day (44mg of diadzein, 16mg glycitein and 10mg genestein) or a placebo for 24 weeks. Results: The isoflavone group increased significantly appendicular (P=0.034), leg (P=0.016) FFM and MMI (P=0.037), but not the placebo group. Conclusion: Six months of isoflavone supplementation increased FFM and MMI in obese-sarcopenic postmenopausal women.
引用
收藏
页码:1442 / 1444
页数:3
相关论文
共 21 条
[1]
HRT provides no additional beneficial effect on sarcopenia in physically active postmenopausal women: a cross-sectional, observational study [J].
Aubertin-Leheudre, M ;
Audet, M ;
Goulet, EDB ;
Dionne, IJ .
MATURITAS, 2005, 51 (02) :140-145
[2]
Epidemiology of sarcopenia among the elderly in New Mexico [J].
Baumgartner, RN ;
Koehler, KM ;
Gallagher, D ;
Romero, L ;
Heymsfield, SB ;
Ross, RR ;
Garry, PJ ;
Lindeman, RD .
AMERICAN JOURNAL OF EPIDEMIOLOGY, 1998, 147 (08) :755-763
[3]
Sarcopenic obesity predicts Instrumental Activities of Daily Living disability in the elderly [J].
Baumgartner, RN ;
Wayne, SJ ;
Waters, DL ;
Janssen, I ;
Gallagher, D ;
Morley, JE .
OBESITY RESEARCH, 2004, 12 (12) :1995-2004
[4]
Fat and protein redistribution with aging:: metabolic considerations [J].
Beaufrère, B ;
Morio, B .
EUROPEAN JOURNAL OF CLINICAL NUTRITION, 2000, 54 (Suppl 3) :S48-S53
[5]
Effects of the phytoestrogen genistein on cardiovascular risk factors in postmenopausal women [J].
Crisafulli, A ;
Altavilla, D ;
Marini, H ;
Bitto, A ;
Cucinotta, D ;
Frisina, N ;
Corrado, F ;
D'Anna, R ;
Squadrito, G ;
Adamo, EB ;
Marini, R ;
Romeo, A ;
Cancellieri, F ;
Buemi, M ;
Squadrito, F .
MENOPAUSE-THE JOURNAL OF THE NORTH AMERICAN MENOPAUSE SOCIETY, 2005, 12 (02) :186-192
[6]
Dragan I., 1992, Revue Roumaine de Physiologie, V29, P63
[7]
Effects of diet and exercise on common cardiovascular disease risk factors in moderately obese older women [J].
Fox, AA ;
Thompson, JL ;
Butterfield, GE ;
Gylfadottir, U ;
Moynihan, S ;
Spiller, G .
AMERICAN JOURNAL OF CLINICAL NUTRITION, 1996, 63 (02) :225-233
[8]
Changes in muscle strength in women following the menopause: a longitudinal assessment of the efficacy of hormone replacement therapy [J].
Greeves, JP ;
Cable, NT ;
Reilly, T ;
Kingsland, C .
CLINICAL SCIENCE, 1999, 97 (01) :79-84
[9]
POSTMENOPAUSAL HORMONE REPLACEMENT THERAPY PREVENTS CENTRAL DISTRIBUTION OF BODY-FAT AFTER MENOPAUSE [J].
HAARBO, J ;
MARSLEW, U ;
GOTFREDSEN, A ;
CHRISTIANSEN, C .
METABOLISM-CLINICAL AND EXPERIMENTAL, 1991, 40 (12) :1323-1326
[10]
Beneficial effects of a soy-based dietary supplement on lipid levels and cardiovascular risk markers in type 2 diabetic subjects [J].
Hermansen, K ;
Sondergaard, M ;
Hoie, L ;
Carstensen, M ;
Brock, B .
DIABETES CARE, 2001, 24 (02) :228-233